Image

Parents as Partners: Effectiveness of the Program in a Portuguese Sample

Parents as Partners: Effectiveness of the Program in a Portuguese Sample

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study aims to assess the effectiveness of the "Parents as Partners" program (also named "Supporting Father Involvement"; Cowan et al., 2009) in a sample of Portuguese couples going through the transition to parenthood, i.e., with one child up to the age of 3 years old. The program aims to strengthen the coparenting relationship and consists of 2-hour 8 weekly group sessions attended by couples. Using a mixed-method approach, the researchers will conduct a randomized clinical trial aiming to assess the effectiveness of the intervention on primary and secondary outcomes. Lastly, participants' perceptions of the intervention usefulness will be assessed by conducting interviews with couples who participated in the intervention group (Parents as Partners).

Description

This study was approved by the Ethics Committee of the Faculty of Psychology and Education Sciences of the University of Porto (Ref. 023/07-17).

The curriculum and assessment approach of "Parents as Partners" is built on a 5-domain risk and protective model: Parents as Individuals- Their health, mental health and general well-being; Parent-Child Relationships- Fathers' and mothers' age-appropriate parenting strategies; Couple Relationship- How parents manage their conflict and disagreement; coparenting that is more collaborative than undermining; Family of Origin Patterns- Parents' developmental histories with their parents; what is carried over from the past; how to interrupt intergenerational cycles of harsh treatment, abuse, and neglect; Stressors and Supports- Parents' strategies for coping with external stressors and enlisting support from family, friends, the workplace, and social services. The sessions will be led by two psychologists (male and female) who underwent 24-hour training by the Brazelton Touchpoints Center. The program has a 10-dimension fidelity assessment model, which will be complemented by session checklists. Furthermore, the facilitators will participate in weekly monitoring sessions with professionals specialized in the program.

Participants will be recruited from nurseries and private clinics.

After enrolling in the program, group facilitators conduct an initial interview to get to know the couple and clarify any questions they may have about the program. At this moment, couples will be asked to sign a consent form. After consenting to their participation, couples will be randomly assigned to one of two conditions: intervention group or waitlist-control group. The estimated sample size is 51 couples for the waitlist-control and intervention group each (power of .80; α = .05; G*Power 3.1.9.7). Participants will be assessed before and after the intervention on (co)parental, dyadic and work-family interface dimensions. Parents in the waitlist-control group will receive the intervention once their participation in the study is finished and if positive outcomes are found.

Hypotheses Group effects: The intervention group (IG) is expected to show an increase in coparenting relationship quality, parenting efficacy, and a decrease in parental stress compared to the wait-list control group (CG). Additionally, the investigators expect fathers in the IG to show an increase in parental involvement compared to those in the CG. As for secondary outcomes, the IG is expected to show an increase in the quality of the couple relationship, partner responsiveness and family-work enrichment, and a decrease in family-work conflict compared to the CG. Additionally, the researchers expect an improvement in child's social and emotional development.

Actor and partner effects: The improvement in parental indicators (e.g., parenting efficacy, parental stress) is expected to impact one's parental involvement and the partner's perception of partner responsiveness and coparenting relationship quality.

Statistical procedures: Intent to treat analysis will be applied. All data will be included regardless of participation rate. Repeated measures MANCOVA will be used to address within and between effects of the intervention, alongside T-Tests for comparing IG and CG, and controlling for mental health. The Actor-Partner Interdependence Model will be applied to assess actor and partner effects using Hierarchical Linear Modeling.

To assess the perceived usefulness of the intervention, 6-10 couples from the IG will be interviewed together using a semi-structured script after the posttest survey is completed. These interviews will be conducted by a researcher who has not been involved in the implementation of the program.

Participants data will be stored in an encrypted file, saved on a computer, and only accessible to the main researchers of this study. Confidentiality will be guaranteed by attributing an individual code to each participant/couple. Interviews will be recorded and transcribed and transcriptions will be marked with the same code to ensure the association of the collected data.

Eligibility

Inclusion Criteria:

  • Heterosexual couples
  • Both members of a couple accept to participate
  • Couples should have only one child who should be up to 3 years of age
  • Both members of the couple must have been parents for the first time together, i.e., they cannot have children from previous relationships
  • Should live together.

Exclusion Criteria:

  • Severe mental health problems,
  • Situations of domestic violence,
  • Problematic use of alcohol and/or drugs.

Study details
    Healthy

NCT06483841

Universidade do Porto

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.